TELA Bio(TELA) - 2025 Q4 - Earnings Call Transcript

TELA Bio (NasdaqGM:TELA) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsCaitlin Roberts - Director of MedTech Equity ResearchJeff Blizard - PresidentJim Hagen - SVP of CommercialLouisa Smith - Investor RelationsRoberto Cuca - COO and CFOTony Koblish - Co Founder and CEOConference Call ParticipantsFrank Takkinen - Senior Research AnalystMatthew O'Brien - Senior Research AnalystMichael Sarcone - Equity Research AnalystOperatorGood afternoon, ladies and gentlemen, and welcome to the TELA ...